Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

He’s Not Here Pays $15,000 Fine

A Brief History of The Pit

New UNC training program helps former military medics transition to civilian health-care jobs

UNC's Kenan-Flagler Business School Recognized For Global Innovation

Chapel Hill sees losses in young professionals


© 2005-2016 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.